Mahmoudjafari, Zahra http://orcid.org/0000-0002-3168-2521
Alencar, Maritza C.
Alexander, Maurice D.
Johnson, Darren J.
Yeh, Jason
Evans, Misty D.
Article History
Received: 17 October 2022
Revised: 1 March 2023
Accepted: 8 March 2023
First Online: 14 April 2023
Competing interests
: ZM discloses advisory activity for Incyte, Omeros, BMS, Merck & Co., and Seattle Genetics. MCA discloses speaking honoraria from Kite Pharma. MDA discloses advisory activity for Merck & Co., EUSA Pharma, Omeros, and AcelRx, and current employment at Merck & Co., after the manuscript was developed. MDE discloses advisory activity with Vertex and Jazz Pharmaceuticals. The following authors declare they have no conflict of interest in this manuscript: DJJ and JY.